8-K
Ascent Industries Co. (ACNT)
View as plain text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 28, 2024
Ascent Industries Co.
(Exact name of registrant as specified in its charter)
| Delaware | 0-19687 | 57-0426694 | ||
|---|---|---|---|---|
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||
| 1400 16th Street, | Suite 270, | |||
| Oak Brook, | Illinois | 60523 | ||
| (Address of principal executive offices) | (Zip Code) | |||
| (630) | 884-9181 | |||
| (Registrant's telephone number, including area code) | ||||
| Inapplicable | ||||
| (Former name or former address if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of exchange on which registered |
|---|---|---|
| Common Stock, par value $1.00 per share | ACNT | NASDAQ Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02. Results of Operations and Financial Condition
On March 28, 2024, Ascent Industries Co. ("the Company") issued a press release announcing financial information for its fourth quarter and fiscal year ended December 31, 2023. The press release is attached as Exhibit 99.1 to this Form 8-K and is furnished to, but not filed with, the Commission.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
| Exhibit Number | Description of Exhibit |
|---|---|
| 99.1 | Ascent Industries Co. Press Release dated March 28, 2024 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on behalf by the undersigned hereunto duly authorized.
| Ascent Industries Co. | |
|---|---|
| Dated: March 28, 2024 | By: /s/ Ryan Kavalauskas |
| Ryan Kavalauskas | |
| Chief Financial Officer |
Document
Exhibit 99.1
Ascent Industries Reports Fourth Quarter and Full Year 2023 Results
Eliminated All Outstanding Debt with Cash Proceeds from the Sale of Specialty Pipe & Tube
New Leadership Focused on Accelerating Profitable Growth and Maximizing Value
Oak Brook, Illinois, March 28, 2024 – Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), an industrials company focused on the production of specialty chemicals and industrial tubular products, is reporting its results for the fourth quarter and full year ended December 31, 2023.
Fourth Quarter 2023 Summary1
| (in millions, except per share and margin) | Q4 2023 | Q4 2022 | Change |
|---|---|---|---|
| Net Sales | $41.2 | $54.2 | (23.9)% |
| Gross Profit | $(2.1) | $4.9 | (143.9)% |
| Gross Profit Margin | (5.2)% | 9.0% | (1,420)bps |
| Net (Loss) Income | $(7.5) | $4.5 | (267.4)% |
| Diluted (Loss) Earnings per Share | $(0.73) | $0.43 | (269.8)% |
| Adjusted EBITDA | $(5.9) | $1.7 | (460.5)% |
| Adjusted EBITDA Margin | (14.4)% | 3.0% | (1,740)bps |
Full Year 2023 Summary1
| (in millions, except per share and margin) | 2023 | 2022 | Change |
|---|---|---|---|
| Net Sales | $193.2 | $262.0 | (26.3)% |
| Gross Profit | $1.5 | $43.3 | (96.5)% |
| Gross Profit Margin | 0.8% | 16.5% | (1,570)bps |
| Net (Loss) Income | $(34.2) | $17.6 | (294.3)% |
| Diluted (Loss) Earnings per share | $(3.37) | $1.69 | (299.4)% |
| Adjusted EBITDA | $(15.9) | $25.6 | (162.3)% |
| Adjusted EBITDA Margin | (8.2)% | 9.8% | (1,800)bps |
________________
1On June 2, 2023, the Board of Directors of Ascent made the decision to permanently cease operations at the Company’s welded pipe and tube facility located in Munhall, PA (“Munhall”) effective on August 31, 2023. On December 22, 2023, the Company closed on a transaction to sell substantially all of the assets of Specialty Pipe & Tube (“SPT”). As a result, financial results from Munhall & SPT have been categorized into discontinued operations.
Management Commentary
“The Ascent team made notable progress towards our long-term strategic goals in 2023, despite continued market headwinds,” said Ascent CEO Bryan Kitchen. “This progress was driven by meaningful initiatives to onboard new customers and unlock operational efficiencies that we expect to bear fruit next year. However, our momentum in the fourth quarter was not sufficient to fully mitigate the adverse effects of industry-wide destocking trends that impacted both business segments. Prior to year-end, Ascent closed on a sale of substantially all of the assets of Specialty Pipe and Tube, generating $55 million in an all-cash transaction. These proceeds were utilized to clear remaining debt, positioning the Company favorably as it entered 2024.
“We moved into 2024 with a healthy financial position and a commitment to driving sustainable earnings-growth across the enterprise. This commitment is underscored by purposeful initiatives to recapitalize talent and capabilities, aimed to maximize the value derived from the unique strengths within our tubular segment while simultaneously investing in the growth potential of the specialty chemicals segment. We believe our newly-assembled management team has already begun to make progress towards our long-term goals focused on creating durable shareholder value.”
Exhibit 99.1
Fourth Quarter 2023 Financial Results
Net sales from continuing operations were $41.2 million compared to $54.2 million in the prior year period, primarily attributable to decreased end-market demand and de-stocking trends across both segments.
Gross profit from continuing operations was $(2.1) million, or (5.2%) of net sales, compared to $4.9 million, or 9.0% of net sales, in the fourth quarter of 2022. The decrease was primarily attributable to elevated costs and unfavorable product mix.
Net loss from continuing operations was $7.5 million, or $(0.73) diluted loss per share, compared to net income from continuing operations of $4.5 million, or $0.43 diluted earnings per share, in the fourth quarter of 2022. The decrease was primarily attributable to the aforementioned lower net sales, along with an increase in administrative expenses.
Adjusted EBITDA was $(5.9) million compared to $1.7 million in the fourth quarter of 2022. Adjusted EBITDA margin was (14.4)% compared to 3.0% in the prior year period. The decrease was primarily attributable to the aforementioned lower net sales.
Full Year 2023 Financial Results
Net sales from continuing operations were $193.2 million compared to $262.0 million in 2022. The decrease was primarily attributable to decreases in volume throughout the year as a result of industry-wide de-stocking trends and challenging end market fundamentals.
Gross profit from continuing operations was $1.5million, or 0.8% of net sales, compared to $43.3 million or 16.5% of net sales in 2022. The decrease was primary attributable to the aforementioned decline in net sales across both segments, along with unfavorable product mix over the prior year.
Net loss from continuing operations was $34.2 million, or $(3.37) diluted loss per share, compared to $17.6 million, or $1.69 diluted earnings per share in 2022. The decrease was primarily attributable to the aforementioned decline in net sales and gross margin.
Adjusted EBITDA was $(15.9) million compared to $25.6 million in 2022. Adjusted EBITDA as a percentage of net sales was (8.2)% compared to 9.8% in the prior year. The decline is primarily attributable to lower operating margins across both segments compared to the prior year.
Segment Results
Ascent Chemicals – net sales in the fourth quarter of 2023 were $18.5 million compared to $23.5 million in the fourth quarter of 2022. Operating loss in the fourth quarter was $1.6 million compared to operating income of $0.9 million in the prior year period. Adjusted EBITDA in the fourth quarter was $(0.4) million compared to $2.0 million in the prior year period. As a percentage of segment net sales, adjusted EBITDA was (2.3)% compared to 8.6% in the fourth quarter of 2022.
Net sales in 2023 were $83.6 million compared to $107.5 million in 2022. Operating loss in 2023 was $12.6 million compared to operating income of $7.0 million in the prior year. Adjusted EBITDA in 2023 was $3.4 million compared to $11.8 million in the prior year. As a percentage of segment net sales, adjusted EBITDA was 4.1% compared to 10.9% in 2022.
Ascent Tubular – net sales from continuing operations in the fourth quarter of 2023 were $22.8 million compared to $30.7 million in the fourth quarter of 2022. Operating loss from continuing operations in the fourth quarter was $4.0 million compared to operating income from continuing operations of $1.2 million in the prior year period. Adjusted EBITDA from continuing operations in the fourth quarter was $(3.1) million compared to $2.1 million in the prior year period. As a percentage of segment net sales, adjusted EBITDA was (13.7)% compared to 6.9% in the fourth quarter of 2022.
Net sales from continuing operations in 2023 was $109.5 million compared to $154.0 million in 2022. Operating loss from continuing operations in 2023 was $11.2 million compared to $22.2 million in the prior year. Adjusted EBITDA from continuing operations in 2023 was $(7.8) million compared to $25.7 million in the prior year. As a percentage of segment net sales, adjusted EBITDA was (7.1)% compared to 16.7% in 2022.
Liquidity
During the fourth quarter of 2023, Ascent announced the sale of substantially all the assets of Specialty Pipe & Tube for approximately $55 million in an all-cash transaction that closed on December 22, 2023. As a result of the sale, the Company paid
Exhibit 99.1
off its remaining balance on the revolving credit facility in the fourth quarter of 2023. As of December 31, 2023, the Company did not have any outstanding debt on its balance sheet and had $61.8 million in availability under its revolving credit facility.
For the year ended December 31, 2023, the Company repurchased 143,108 shares at an average cost of $8.97 per share for approximately $1.3 million.
Conference Call
Ascent will conduct a conference call today at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2023.
Ascent management will host the conference call, followed by a question and answer period.
Date: Thursday, March 28, 2024
Time: 5:00 p.m. Eastern time
Live Call Registration Link: Here
Webcast Registration Link: Here
To access the call by phone, please register via the live call registration link above or here and you will be provided with dial-in instructions and details. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.
The conference call will also be broadcast live and available for replay via the webcast registration link above or here. The webcast will be archived for one year in the investor relations section of the Company’s website at www.ascentco.com.
About Ascent Industries Co.
Ascent Industries Co. (Nasdaq: ACNT) is a company that engages in a number of diverse business activities including the production of specialty chemicals and industrial tubular products. For more information about Ascent, please visit its website at www.ascentco.com.
Forward-Looking Statements
This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks as set forth in more detail in Ascent Industries Co.’s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC or on our website. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release.
Non-GAAP Financial Information
Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.
Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, earn-out adjustments, , retention costs and restructuring & severance costs from net income.
Exhibit 99.1
Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.
Company Contact
Ryan Kavalauskas
Chief Financial Officer
1-630-884-9181
Investor Relations
Cody Slach and Cody Cree
Gateway Group, Inc.
1-949-574-3860
ACNT@gateway-grp.com
Ascent Industries Co.
Condensed Consolidated Balance Sheets
(in thousands, except par value and share data)
| December 31, 2023 | December 31, 2022 | |||
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | $ | 1,851 | $ | 1,440 |
| Accounts receivable, net of allowance for credit losses of $463 and $643, respectively | 26,604 | 33,202 | ||
| Inventories | 52,306 | 67,671 | ||
| Prepaid expenses and other current assets | 4,879 | 7,770 | ||
| Assets held for sale | 2,912 | 380 | ||
| Current assets of discontinued operations | 861 | 59,912 | ||
| Total current assets | 89,413 | 170,375 | ||
| Property, plant and equipment, net | 29,755 | 35,534 | ||
| Right-of-use assets, operating leases, net | 27,784 | 29,142 | ||
| Goodwill | — | 11,389 | ||
| Intangible assets, net | 8,496 | 10,001 | ||
| Deferred income taxes | 5,808 | 1,353 | ||
| Deferred charges, net | 104 | 203 | ||
| Other non-current assets, net | 1,935 | 1,862 | ||
| Long-term assets of discontinued operations | — | 9,184 | ||
| Total assets | $ | 163,295 | $ | 269,043 |
| Liabilities and Shareholders' Equity | ||||
| Current liabilities: | ||||
| Accounts payable | $ | 16,416 | $ | 14,114 |
| Accrued expenses and other current liabilities | 5,108 | 5,509 | ||
| Current portion of note payable | 360 | 387 | ||
| Current portion of long-term debt | — | 2,464 | ||
| Current portion of operating lease liabilities | 1,140 | 1,015 | ||
| Current portion of finance lease liabilities | 292 | 280 | ||
| Current liabilities of discontinued operations | 1,473 | 9,709 | ||
| Total current liabilities | 24,789 | 33,478 | ||
| Long-term debt | — | 69,085 | ||
| Long-term portion of operating lease liabilities | 29,729 | 30,869 | ||
| Long-term portion of finance lease liabilities | 1,307 | 1,242 | ||
| Other long-term liabilities | 60 | 68 | ||
| Long-term liabilities of discontinued operations | — | 42 | ||
| Total non-current liabilities | 31,096 | 101,306 | ||
| Total liabilities | $ | 55,885 | $ | 134,784 |
| Commitments and contingencies | ||||
| Shareholders' equity: | ||||
| Common stock, par value $1 per share; 24,000,000 shares authorized; 11,085,103 and 10,094,821 shares issued and outstanding, respectively | $ | 11,085 | $ | 11,085 |
| Capital in excess of par value | 47,333 | 47,021 | ||
| Retained earnings | 58,517 | 85,146 | ||
| 116,935 | 143,252 | |||
| Less: cost of common stock in treasury - 990,282 and 924,504 shares, respectively | (9,525) | (8,993) | ||
| Total shareholders' equity | 107,410 | 134,259 | ||
| Total liabilities and shareholders' equity | $ | 163,295 | $ | 269,043 |
Note: The condensed consolidated balance sheets at December 31, 2023 and 2022 have been derived from the audited consolidated financial statements at that date.
Ascent Industries Co.
Condensed Consolidated Statements of Income (Loss) - Comparative Analysis (Unaudited)
($ in thousands, except per share data)
| Three Months Ended <br>December 31, | Year Ended <br>December 31, | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | ||||||
| Net sales | |||||||||
| Tubular Products | $ | 22,765 | $ | 30,697 | $ | 109,513 | $ | 154,040 | |
| Specialty Chemicals | 18,451 | 23,473 | 83,616 | 107,542 | |||||
| All Other | — | 10 | 50 | 411 | |||||
| 41,216 | 54,180 | 193,179 | 261,993 | ||||||
| Operating income (loss) from continuing operations | |||||||||
| Tubular Products | (3,995) | 1,232 | (11,210) | 22,182 | |||||
| Specialty Chemicals | (1,623) | 860 | (12,558) | 6,971 | |||||
| All Other | (116) | (175) | (801) | (508) | |||||
| Corporate | |||||||||
| Unallocated corporate expenses | (2,704) | (2,761) | (12,018) | (12,997) | |||||
| Acquisition costs and other | (569) | (266) | (843) | (1,105) | |||||
| Total Corporate | (3,273) | (3,027) | (12,861) | (14,102) | |||||
| Operating (loss) income | (9,007) | (1,110) | (37,430) | 14,543 | |||||
| Interest expense | 1,021 | 1,104 | 4,238 | 2,742 | |||||
| Other, net | (249) | (34) | (593) | (209) | |||||
| (Loss) income from continuing operations before income taxes | (9,779) | (2,180) | (41,075) | 12,010 | |||||
| Income tax benefit | (2,244) | (6,681) | (6,924) | (5,568) | |||||
| (Loss) income from continuing operations | (7,535) | 4,501 | (34,151) | 17,578 | |||||
| Income (loss) from discontinued operations, net of tax | 18,674 | (4,374) | 7,522 | 4,488 | |||||
| Net income (loss) | $ | 11,139 | $ | 127 | $ | (26,629) | $ | 22,066 | |
| Net (loss) income per common share from continuing operations | |||||||||
| Basic | $ | (0.75) | $ | 0.44 | $ | (3.37) | $ | 1.72 | |
| Diluted | $ | (0.73) | $ | 0.43 | $ | (3.37) | $ | 1.69 | |
| Net income (loss) per common share from discontinued operations | |||||||||
| Basic | $ | 1.85 | $ | (0.43) | $ | 0.74 | $ | 0.44 | |
| Diluted | $ | 1.80 | $ | (0.42) | $ | 0.74 | $ | 0.43 | |
| Net income (loss) per common share | |||||||||
| Basic | $ | 1.10 | $ | 0.01 | $ | (2.63) | $ | 2.16 | |
| Diluted | $ | 1.07 | $ | 0.01 | $ | (2.63) | $ | 2.12 | |
| Average shares outstanding | |||||||||
| Basic | 10,107 | 10,213 | 10,140 | 10,230 | |||||
| Diluted | 10,374 | 10,416 | 10,140 | 10,410 | |||||
| Other data: | |||||||||
| Adjusted EBITDA1 | $ | (5,941) | $ | 1,648 | $ | (15,934) | $ | 25,590 |
1The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, loss on extinguishment of debt, earn-out adjustments, retention costs and restructuring & severance costs from net income. For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.
Ascent Industries Co.
Consolidated Statements of Cash Flows
($ in thousands)
| Year Ended December 31, | ||||
|---|---|---|---|---|
| 2023 | 2022 | |||
| Operating activities | ||||
| Net (loss) income | $ | (26,629) | $ | 22,066 |
| Net income from discontinued operations, net of tax | 7,522 | 4,488 | ||
| Net (loss) income from continuing operations | (34,151) | 17,578 | ||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||
| Depreciation expense | 6,161 | 6,421 | ||
| Amortization expense | 1,505 | 1,853 | ||
| Amortization of debt issuance costs | 99 | 99 | ||
| Goodwill impairment | 11,389 | — | ||
| Deferred income taxes | (6,924) | (5,568) | ||
| Payments of earn-out liabilities in excess of acquisition date fair value | — | (372) | ||
| Provision for losses on accounts receivable | (180) | 478 | ||
| Provision for losses on inventories | 3,318 | 2,615 | ||
| Loss (gain) on disposal of property, plant and equipment | 246 | (18) | ||
| Non-cash lease expense | 242 | 414 | ||
| Issuance of treasury stock for director fees | — | 364 | ||
| Stock-based compensation expense | 1,023 | 1,355 | ||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | 6,778 | (264) | ||
| Inventories | 12,245 | (13,685) | ||
| Other assets and liabilities | 515 | (211) | ||
| Accounts payable | 1,650 | (6,269) | ||
| Accounts payable - related parties | — | (2) | ||
| Accrued expenses | (401) | (2,127) | ||
| Accrued income taxes | 3,129 | (7,923) | ||
| Net cash provided by (used in) operating activities - continuing operations | 6,644 | (5,262) | ||
| Net cash provided by operating activities - discontinued operations | 16,434 | 10,839 | ||
| Net cash provided by operating activities | 23,078 | 5,577 | ||
| Investing activities | ||||
| Purchases of property, plant and equipment | (2,885) | (3,394) | ||
| Proceeds from disposal of property, plant and equipment | — | 99 | ||
| Net cash used in investing activities - continuing operations | (2,885) | (3,295) | ||
| Net cash provided by (used in) investing activities - discontinued operations | 53,386 | (1,680) | ||
| Net cash provided by (used in) investing activities | 50,501 | (4,975) | ||
| Financing activities | ||||
| Borrowings from long-term debt | 256,606 | 443,363 | ||
| Proceeds from note payable | 900 | 967 | ||
| Proceeds from the exercise of stock options | — | 175 | ||
| Payments on long-term debt | (328,155) | (442,206) | ||
| Payments on note payable | (928) | (580) | ||
| Principal payments on finance lease obligations | (305) | (266) | ||
| Payments on earn-out liabilities | — | (484) | ||
| Repurchase of common stock | (1,287) | (1,343) | ||
| Net cash used in financing activities - continuing operations | (73,169) | (374) | ||
| Net cash used in financing activities - discontinued operations | — | (808) | ||
| Net cash used in financing activities | (73,169) | (1,182) | ||
| Increase (decrease) in cash and cash equivalents | 410 | (580) | ||
| Less: Cash and cash equivalents of discontinued operations | — | 4 | ||
| Cash and cash equivalents, beginning of period | 1,441 | 2,017 | ||
| Cash and cash equivalents, end of period | $ | 1,851 | $ | 1,441 |
Ascent Industries Co.
Non-GAAP Financial Measures Reconciliation
Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited)
($ in thousands)
| Three Months Ended <br>December 31, | Year Ended <br>December 31, | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( in thousands) | 2023 | 2022 | 2023 | 2022 | ||||||||
| Consolidated | ||||||||||||
| Net (loss) income from continuing operations | $ | (7,535) | $ | 4,501 | $ | (34,151) | $ | 17,578 | ||||
| Adjustments: | ||||||||||||
| 1,021 | 1,104 | 4,238 | 2,742 | |||||||||
| (2,244) | (6,681) | (6,924) | (5,568) | |||||||||
| 1,527 | 1,579 | 6,161 | 6,421 | |||||||||
| 376 | 429 | 1,505 | 1,853 | |||||||||
| EBITDA | (6,855) | 932 | (29,171) | 23,026 | ||||||||
| 579 | 266 | 856 | 1,104 | |||||||||
| — | 12 | — | 12 | |||||||||
| — | — | 11,389 | — | |||||||||
| — | — | — | (2) | |||||||||
| 224 | 283 | 594 | 962 | |||||||||
| 52 | 91 | 242 | 414 | |||||||||
| 20 | — | 26 | — | |||||||||
| 39 | 64 | 130 | 74 | |||||||||
| Adjusted EBITDA | $ | (5,941) | $ | 1,648 | $ | (15,934) | $ | 25,590 | ||||
| (14.4) | % | 3.0 | % | (8.2) | % | 9.8 | % |
All values are in US Dollars.
| Tubular Products | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net (loss) income from continuing operations | $ | (3,995) | $ | 1,232 | $ | (11,210) | $ | 22,182 | |||||
| Adjustments: | |||||||||||||
| Depreciation expense | 557 | 609 | 2,274 | 2,500 | |||||||||
| Amortization expense | 217 | 238 | 871 | 951 | |||||||||
| EBITDA | (3,221) | 2,079 | (8,065) | 25,633 | |||||||||
| Stock-based compensation | 74 | 11 | 58 | 46 | |||||||||
| Non-cash lease expense | 25 | — | 118 | — | |||||||||
| Retention expense | 8 | — | 8 | — | |||||||||
| Restructuring and severance costs | — | 20 | 84 | 20 | |||||||||
| Tubular Products Adjusted EBITDA | $ | (3,114) | $ | 2,110 | $ | (7,797) | $ | 25,699 | |||||
| % segment sales | (13.7) | % | 6.9 | % | (7.1) | % | 16.7 | % | |||||
| Specialty Chemicals | |||||||||||||
| Net (loss) income | $ | (1,644) | $ | 852 | $ | (12,619) | $ | 6,935 | |||||
| Adjustments: | |||||||||||||
| Interest expense | 22 | 9 | 74 | 36 | |||||||||
| Depreciation expense | 948 | 949 | 3,798 | 3,846 | |||||||||
| Amortization expense | 158 | 191 | 634 | 903 | |||||||||
| EBITDA | (516) | 2,001 | (8,113) | 11,720 | |||||||||
| Acquisition costs and other | 10 | — | 12 | — | |||||||||
| Goodwill impairment | — | — | 11,389 | — | |||||||||
| Stock-based compensation | 21 | 12 | 8 | 41 | |||||||||
| Non-cash lease expense | 19 | — | 88 | 2 | |||||||||
| Restructuring and severance costs | 40 | 8 | 40 | 8 | |||||||||
| Specialty Chemicals Adjusted EBITDA | $ | (426) | $ | 2,021 | $ | 3,424 | $ | 11,771 | |||||
| % segment sales | (2.3) | % | 8.6 | % | 4.1 | % | 10.9 | % |
8